Search research articles
Contact Us
Filters
Showing results (11-20 of 65) with videos related to
Page
of 7
Sort By:
Seminars in Hematology
|
February 28, 2009
Recognizing and treating secondary immune thrombocytopenic purpura associated with lymphoproliferative disorders
Howard A Liebman
Thrombosis Research
|
April 13, 2016
Incidental venous thromboembolic events in cancer patients: what we know in 2016
Howard A Liebman, Casey O'Connell
Biologics : Targets & Therapy
|
August 27, 2009
Anti-RhD immunoglobulin in the treatment of immune thrombocytopenia
Eric Cheung, Howard A Liebman
Hematology. American Society of Hematology. Education Program
|
December 14, 2011
Diagnosis and management of immune thrombocytopenia in the era of thrombopoietin mimetics
Howard A Liebman, Vinod Pullarkat
Hematology/Oncology Clinics of North America
|
November 26, 2009
Thyroid disease in patients with immune thrombocytopenia
Eric Cheung, Howard A Liebman
British Journal of Haematology
|
October 9, 2003
Successful treatment of refractory pure red cell aplasia associated with lymphoproliferative disorders with the anti-CD52 monoclonal antibody alemtuzumab (Campath-1H)
Xiuqing Ru, Howard A Liebman
Current Opinion in Hematology
|
October 16, 2007
Secondary immune thrombocytopenic purpura
Howard A Liebman, Roberto Stasi
Research and Practice in Thrombosis and Haemostasis
|
September 1, 2021
Corticosteroid overuse in adults with immune thrombocytopenia: Cause for concern
Adam Cuker, Howard A Liebman
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 2, 2014
Approach to the management of incidental venous thromboembolic events in patients with cancer
Casey L O'Connell, Howard A Liebman
Hematology/Oncology Clinics of North America
|
November 26, 2009
The immune thrombocytopenia syndrome: a disorder of diverse pathogenesis and clinical presentation
Douglas B Cines, Howard A Liebman
Page
of 7
Search research articles
Search
Showing results (11-20 of 65) with videos related to
Sort By:
Page
of 7
Seminars in Hematology
|
February 28, 2009
Recognizing and treating secondary immune thrombocytopenic purpura associated with lymphoproliferative disorders
Howard A Liebman
Thrombosis Research
|
April 13, 2016
Incidental venous thromboembolic events in cancer patients: what we know in 2016
Howard A Liebman, Casey O'Connell
Biologics : Targets & Therapy
|
August 27, 2009
Anti-RhD immunoglobulin in the treatment of immune thrombocytopenia
Eric Cheung, Howard A Liebman
Hematology. American Society of Hematology. Education Program
|
December 14, 2011
Diagnosis and management of immune thrombocytopenia in the era of thrombopoietin mimetics
Howard A Liebman, Vinod Pullarkat
Hematology/Oncology Clinics of North America
|
November 26, 2009
Thyroid disease in patients with immune thrombocytopenia
Eric Cheung, Howard A Liebman
British Journal of Haematology
|
October 9, 2003
Successful treatment of refractory pure red cell aplasia associated with lymphoproliferative disorders with the anti-CD52 monoclonal antibody alemtuzumab (Campath-1H)
Xiuqing Ru, Howard A Liebman
Current Opinion in Hematology
|
October 16, 2007
Secondary immune thrombocytopenic purpura
Howard A Liebman, Roberto Stasi
Research and Practice in Thrombosis and Haemostasis
|
September 1, 2021
Corticosteroid overuse in adults with immune thrombocytopenia: Cause for concern
Adam Cuker, Howard A Liebman
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 2, 2014
Approach to the management of incidental venous thromboembolic events in patients with cancer
Casey L O'Connell, Howard A Liebman
Hematology/Oncology Clinics of North America
|
November 26, 2009
The immune thrombocytopenia syndrome: a disorder of diverse pathogenesis and clinical presentation
Douglas B Cines, Howard A Liebman
Page
of 7